| Quarterly Financials | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 10 | 34 | 88 | 76 | 80 | 338 | 399 | 429 |
| Expenses | 80 | 105 | 173 | 76 | 73 | 263 | 351 | 244 |
| EBITDA | -70 | -71 | -85 | -0 | 7 | 76 | 48 | 185 |
| Operating Profit % | -800 % | -210 % | -207 % | -4 % | 7 % | 21 % | 11 % | 43 % |
| Depreciation | 19 | 18 | 20 | 20 | 19 | 68 | 69 | 69 |
| Interest | 18 | 25 | 26 | 21 | 20 | 45 | 46 | 33 |
| Profit Before Tax | -107 | -114 | -130 | -40 | -33 | -38 | -67 | 83 |
| Tax | 0 | 0 | 0 | 0 | 0 | 5 | 2 | -16 |
| Net Profit | -107 | -114 | -130 | -40 | -33 | -42 | -69 | 99 |
| EPS in ₹ | 0.00 | -27.37 | -31.32 | -9.67 | -7.90 | -10.13 | -6.31 | 8.61 |
Onesource Specialty Pharma
2,025.30
+48.60
(2.46%)
There are new updates from the company1 day ago
View
Market Cap
23,176.73 Cr
EPS
-94.15
PE Ratio
276.73
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
2,115.00
52 Week Low
1,209.95
PB Ratio
3.85
Debt to Equity
1.22
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
ONESOURCE Specialty Pharma has received a 'Voluntary Action Indicated' (VAI) classification from the US Food and Drug Administration (USFDA) for its key facility in Bangalore, India. This classification validates the company's ongoing compliance with regulatory standards.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,687.80 | #1 4,04,959.76 | 35.29 | #1 49,887.20 | 12.06 | #1 9,648 | -18.99 | 46.16 | |
6,667.00 | 1,76,987.90 | 81.46 | 8,184.00 | 0.89 | 1,600 | 23.05 | 60.61 | |
1,505.20 | 1,21,562.20 | 23.01 | 26,520.70 | 14.17 | 4,155 | 30.28 | 53.87 | |
1,362.50 | 1,13,694.54 | 20.11 | 28,905.40 | 12.36 | 5,578 | 21.14 | 84.56 | |
3,252.50 | 1,10,079.38 | 57.23 | 10,785.70 | 11.59 | 1,656 | 10.91 | 56.97 | |
2,381.30 | 98,247.32 | 49.58 | 10,615.60 | 19.57 | 1,942 | -10.91 | 43.09 | |
974.95 | 98,102.78 | 21.09 | 19,831.50 | 13.82 | 3,831 | -0.19 | 71.52 | |
1,999.60 | 91,289.93 | 28.14 | 20,141.50 | #1 19.94 | 1,936 | #1 112.49 | 49.72 | |
31,515.00 | 66,967.18 | 47.29 | 6,097.20 | 10.80 | 1,201 | 27.83 | 59.42 | |
1,150.20 | 66,803.80 | #1 19.42 | 29,559.20 | 17.55 | 3,169 | -0.50 | 44.60 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
325.36 %
Net Income Growth
-12.01 %
Cash Flow Change
34.18 %
ROE
74.62 %
ROCE
26.56 %
EBITDA Margin (Avg.)
-87.50 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,258 | 2,442 | 2,009 | 1,309 |
| Fixed Assets | 633 | 1,231 | 1,361 | 863 |
| Current Assets | 99 | 511 | 228 | 176 |
| Capital Work in Progress | 431 | 490 | 335 | 188 |
| Investments | 0 | 0 | 5 | 20 |
| Other Assets | 195 | 722 | 309 | 238 |
| Total Liabilities | 1,258 | 2,442 | 2,009 | 1,309 |
| Current Liabilities | 161 | 809 | 865 | 631 |
| Non Current Liabilities | 321 | 621 | 358 | 282 |
| Total Equity | 776 | 1,013 | 786 | 396 |
| Reserve & Surplus | 775 | 1,009 | 781 | 392 |
| Share Capital | 2 | 3 | 4 | 4 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 56 | 55 | -112 | 13 |
| Investing Activities | -207 | -692 | -68 | 511 |
| Operating Activities | -118 | -416 | -163 | -107 |
| Financing Activities | 381 | 1,162 | 118 | -391 |
Share Holding
| % Holding | Dec 2024 | Mar 2025 |
| Promoter | 37.77 % | 34.25 % |
| FIIs | 17.44 % | 18.54 % |
| DIIs | 12.56 % | 18.04 % |
| Government | 0.00 % | 0.00 % |
| Public / Retail | 13.05 % | 12.96 % |
| Others | 19.18 % | 16.20 % |
| No of Share Holders | 98,425 | 82,712 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
No dividends have been distributed by the company in the past 10 years
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 05 May 2025 |  Quarterly Result Announcement | NA | 05 May 2025 | 1,593.85 | 1,593.00 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 0.00 | 1,536.60 |
| 06 Dec 2024 |  Merger - Demerger | 2:1 | 06 Dec 2024 | 0.00 | 0.00 |
| 06 Dec 2024 | Merger - Demerger | 1:1515 | 06 Dec 2024 | 0.00 | 0.00 |
| 14 Feb 2024 |  Change Of Name | NA | 14 Feb 2024 | 0.00 | 0.00 |
Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
4 days agoGeneral-Updates4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Credit Rating10 days ago
10 days agoAnnouncement Under Regulation 30 Of SEBI (LODR) Regulations 2015May 30, 2025
May 30, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 27, 2025
May 27, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 12, 2025
May 12, 2025Announcement Under Regulation 30.May 09, 2025
May 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 08, 2025
May 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2025
May 07, 2025Intimation Of Investor Meet Held On May 06 2025May 06, 2025
May 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 05, 2025
May 05, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 05, 2025
May 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 29, 2025
Apr 29, 2025Board Meeting Intimation for Prior Intimation Of Board MeetingApr 29, 2025
Apr 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 26, 2025
Apr 26, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 25, 2025
Apr 25, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressApr 23, 2025
Apr 23, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 23, 2025
Apr 23, 2025Update On Scheme Of ArrangementApr 11, 2025
Apr 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 10, 2025
Apr 10, 2025Announcement Under Regulation 30 SEBI(LODR) Regulations 2015_UpdatesApr 09, 2025
Apr 09, 2025Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderMar 13, 2025
Mar 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 03, 2025
Mar 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Feb 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2025
Feb 27, 2025Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.Feb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Credit RatingFeb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2025
Feb 20, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 14, 2025
Feb 14, 2025Intimation Of Financial Results For The Quarter Ended September 302024 In Reply To The Exchange CommunicationFeb 06, 2025
Feb 06, 2025Intimation Of Transcript Of Investors CallFeb 04, 2025
Feb 04, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 03, 2025
Feb 03, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jan 31, 2025
Jan 31, 2025Intimation Of Newspaper Advertisement Of Financial ResultsJan 30, 2025
Jan 30, 2025Intimation Of The Link Of The Audio Recording Of The Investor Call Held On 29Th January 2025.Jan 30, 2025
Jan 30, 2025Integrated Filing (Financial)Jan 29, 2025
Jan 29, 2025Statement Of Investor Complaints For The Quarter Ended December 31 2024Jan 29, 2025
Jan 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 29, 2025
Jan 29, 2025Results-Financial Results For The Quarter Ended December 31. 2024Jan 29, 2025
Jan 29, 2025Board Meeting Outcome for Approval Of The Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended December 31 2024Jan 29, 2025
Jan 29, 2025Technical Indicators
RSI(14)
Neutral 68.53
ATR(14)
Volatile 92.26
STOCH(9,6)
Neutral 72.78
STOCH RSI(14)
Neutral 49.66
MACD(12,26)
Bullish 12.11
ADX(14)
Strong Trend 44.41
UO(9)
Bearish 52.93
ROC(12)
Uptrend And Accelerating 15.43
WillR(14)
Neutral -24.38
Mutual Fund Holdings
| Funding House | No of Shares | Current Holding % | 1M Change % | 3M Change % | Month | |
|---|---|---|---|---|---|---|
 Axis Small Cap Fund Direct-Growth | 609861 | 0.47% | 0.21% | 0.18% | May 2025 | |
 Motilal Oswal Large and Midcap Fund Direct - Growth | 1486003 | 2.63% | 0.36% | 0.10% | May 2025 | |
| Motilal Oswal Balanced Advantage Fund Direct-Growth | 124725 | 2.60% | -0.93% | -1.14% | May 2025 | |
| Motilal Oswal Manufacturing Fund Direct-Growth | 173000 | 4.19% | 1.16% | 1.43% | May 2025 | |
 WhiteOak Capital Flexi Cap Fund Direct - Growth | 86914 | 0.33% | 0.14% | 0.12% | May 2025 | |
 LIC MF Aggressive Hybrid Fund Direct-Growth | 0 | 0.00% | -1.02% | -1.22% | May 2025 | |
| WhiteOak Capital Mid Cap Fund Direct - Growth | 71170 | 0.43% | 0.16% | 0.12% | May 2025 | |
| Axis Equity Savings Fund Direct-Growth | 12113 | 0.25% | -0.32% | -0.36% | May 2025 | |
| WhiteOak Capital Multi Cap Fund Direct - Growth | 50269 | 0.51% | 0.19% | 0.12% | May 2025 | |
| LIC MF Healthcare Fund Direct - Growth | 7332 | 1.67% | -1.09% | -1.45% | May 2025 | |
| WhiteOak Capital ELSS Tax Saver Fund Direct - Growth | 9256 | 0.46% | 0.17% | 0.13% | May 2025 | |
| Motilal Oswal Active Momentum Fund Direct - Growth | 13139 | 3.46% | 0.23% | 0.03% | May 2025 | |
 JM Small Cap Fund Direct - Growth | 90438 | 2.41% | 0.13% | -0.20% | May 2025 | |
 Bandhan Small Cap Fund Direct-Growth | 200495 | 0.33% | 0.01% | -0.04% | May 2025 | |
| JM Focused Direct Plan-Growth | 41100 | 2.83% | 0.32% | -0.02% | May 2025 | |
 Mirae Asset Equity Savings Fund Direct - Growth | 38901 | 0.52% | 0.07% | 0.02% | May 2025 | |
| Motilal Oswal Business Cycle Fund Direct-Growth | 175000 | 1.76% | 0.13% | -0.22% | May 2025 | |
 Groww Nifty Total Market Index Fund Direct - Growth | 0 | 0.00% | 0.00% | 0.00% | May 2025 | |
 ITI Large & Mid Cap Fund Direct-Growth | 26450 | 0.59% | 0.05% | -0.01% | May 2025 | |
| ITI Pharma and Healthcare Fund Direct - Growth | 12527 | 1.09% | 0.16% | 0.06% | May 2025 | |
| JM ELSS Tax Saver Fund Direct Plan-Growth | 28195 | 2.73% | 0.30% | 0.04% | May 2025 | |
| JM Flexicap Fund Direct Plan-Growth | 419059 | 1.36% | 0.15% | 0.05% | May 2025 | |
| JM Large Cap Fund Direct Plan-Growth | 0 | 0.00% | 0.00% | 0.00% | May 2025 | |
| Bandhan Nifty Total Market Index Fund Direct-Growth | 0 | 0.00% | 0.00% | 0.00% | May 2025 | |
| Bandhan Midcap Fund Direct-Growth | 23256 | 0.27% | 0.03% | 0.00% | May 2025 |
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
